ALGN Jan 2025 400.000 put
| Previous close | 97.65 |
| Open | 97.65 |
| Bid | 123.70 |
| Ask | 129.40 |
| Strike | 400.00 |
| Expiry date | 2025-01-17 |
| Day's range | 97.65 - 97.65 |
| Contract range | N/A |
| Volume | |
| Open interest | 9 |
Business WireAlign Technology to Speak at Upcoming Financial Conferences
TEMPE, Ariz., May 24, 2023--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at upcoming financial conferences. The presentations, as noted below, will be webcast live via the Investor Relations section of Align Technology's we
Motley Fool3 Breakout Growth Stocks You Can Buy and Hold for the Next Decade
Let's face it: 2023 has been all about the growth stocks. If you need proof, compare the year-to-date performances of the Vanguard Growth ETF and the Vanguard Value ETF. With that in mind, let's have a look at three growth stocks that have been doing well in the near term that are also long-term buy-and-hold candidates: CrowdStrike Holdings (NASDAQ: CRWD), Align Technology (NASDAQ: ALGN), and Nvidia (NASDAQ: NVDA).
Motley Fool2 Stocks With Unstoppable Growth Potential for the Next Decade
When a business is making headway in a massive and uncontested global market, shareholders reap the benefits. The result could well be a run of wild growth over the next few years. Align Technology's (NASDAQ: ALGN) business model is simple: It sells its Invisalign tooth straighteners to dentists and orthodontists, who use its scanning and 3D modeling devices to adapt the straighteners to fit their patients -- thus eliminating the need to get traditional braces.
ZacksCompared to Estimates, Align Technology (ALGN) Q1 Earnings: A Look at Key Metrics
Although the revenue and EPS for Align Technology (ALGN) give a sense of how its business performed in the quarter ended March 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Business WireAlign Technology to Speak at Upcoming Financial Conference
TEMPE, Ariz., May 03, 2023--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at the following upcoming financial conference. The presentation, as noted below, will be webcast live via the Investor Relations section of Align Tec
ZacksIs AmerisourceBergen (ABC) Outperforming Other Medical Stocks This Year?
Here is how AmerisourceBergen (ABC) and Align Technology (ALGN) have performed compared to their sector so far this year.
Simply Wall St.Is Align Technology, Inc. (NASDAQ:ALGN) Expensive For A Reason? A Look At Its Intrinsic Value
Key Insights Using the 2 Stage Free Cash Flow to Equity, Align Technology fair value estimate is US$259 Align...
Motley FoolWhy Shares of Align Technology Fell Thursday
Shares of Align Technology (NASDAQ: ALGN) were down more than 10% late Thursday afternoon after the healthcare company announced first-quarter earnings. Invisalign teeth aligners have the advantage of being more comfortable and discreet compared to traditional metal braces. It was also the second consecutive quarter that the company had better numbers sequentially.
ZacksAlign Technology (ALGN) Q1 Earnings Beat, Margins Contract
Align Technology (ALGN) delivers better-than-expected revenues and earnings in the first quarter of 2023 but suffers significant foreign currency woes.
Motley FoolThese 2 Stocks Moved the Nasdaq After Hours
Investors remained on uncertain footing on Wednesday, with major stock market benchmarks finishing the day sharply mixed. The Nasdaq Composite (NASDAQINDEX: ^IXIC) held up quite well, powered upward by strong earnings on Tuesday night from key tech giants. Meta Platforms (NASDAQ: META) saw its stock soar after offering reassuring signs that the social media pioneer will continue to be diligent in controlling its costs.
ZacksAlign Technology (ALGN) Q1 Earnings and Revenues Top Estimates
Align Technology (ALGN) delivered earnings and revenue surprises of 7.69% and 3.84%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Business WireAlign Technology Announces First Quarter 2023 Financial Results
TEMPE, Ariz., April 26, 2023--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for the first quarter ("Q1'23"). Q1'23 total revenues were $943.1 million, up 4.6% sequentially and down 3.1% year-over-year. Q1'23 Clear Aligner revenues were $789.8 mil
ZacksMedTech Stocks' Q1 Earnings on Apr 25: BSX, TMO and More
MedTech companies' results are likely to reflect a sequential decline. Let's see how BSX, TMO, EW and ALGN fare this time.
ZacksSTERIS (STE) Set to Post Q4 Earnings: What's in the Cards?
STERIS' (STE) fourth-quarter fiscal 2023 results are likely to reflect an impressive performance across the Healthcare and AST segments, with a gradual improvement in the supply chain.
ZacksShould You Buy Align Technology (ALGN) Ahead of Earnings?
Align Technology (ALGN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Motley Fool2 Must-Own Stocks to Supercharge Your Portfolio
Instead, it's a good idea to go with a couple of must-buy, time-tested businesses that aren't about to have their share prices crash overnight. Align Technology (NASDAQ: ALGN) has a simple yet consistently successful business model that makes it a must-own stock. It develops the Invisalign series of transparent tooth straighteners that people all over the world use instead of older (and significantly less comfortable) tooth straightening devices like braces.
ZacksBioRad Laboratories (BIO) to Post Q1 Earnings: What's in Store?
Bio-Rad Laboratories' (BIO) first-quarter 2023 results are likely to reflect an impressive performance across its Life Science segment, with a gradual reduction in backlogs and an improvement in the supply chain.
ZacksThe Zacks Analyst Blog Highlights General Electric, Kimberly-Clark, Corning, Raytheon Technologies and Align Technology
General Electric, Kimberly-Clark, Corning, Raytheon Technologies and Align Technology are included in this Analyst Blog.
Business WireAlign Technology Honored as Technology Partner of the Year at Junior Achievement of Northern California 2023 Business Hall of Fame
TEMPE, Ariz. & SAN FRANCISCO, April 21, 2023--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Align Technology has been honored as a "Technology Partner of the Year" by Junior Achievement of Northern California (JA NorCal) at the Junior Achievement of Northern
ZacksIDEXX Laboratories (IDXX) to Post Q1 Earnings: What's in Store?
IDEXX Laboratories' (IDXX) first-quarter 2023 results are expected to reflect an impressive performance in the CAG segment despite inflationary impacts.
Zacks5 U.S. Corporate Bigwigs Set to Beat on Q1 Earnings Next Week
We have narrowed our search to five U.S. corporate bigwigs that are set to report first-quarter 2023 earnings results next week. These are: GE, KMB, GLW, RTX and ALGN.
ZacksHere's How Much You'd Have If You Invested $1000 in Align Technology a Decade Ago
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
ZacksQuest Diagnostics (DGX) to Post Q1 Earnings: What's in Store?
Quest Diagnostics' (DGX) first-quarter 2023 results are likely to reflect an impressive performance in its non-COVID-19 base business amid inflationary pressure and labor challenges.
ZacksAlign Technology (ALGN) Expected to Beat Earnings Estimates: Should You Buy?
Align Technology (ALGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksAlign Technology (ALGN) to Post Q1 Earnings: What's in Store?
Align Technology's (ALGN) first-quarter 2023 results are likely to witness impressive performance across its operating segments amid macroeconomic pressure.
